Suivre
Gulenay Guner
Gulenay Guner
GSK, Senior Scientist
Adresse e-mail validée de gsk.com
Titre
Citée par
Citée par
Année
Mechanistic modeling of wet stirred media milling for production of drug nanosuspensions
E Bilgili, G Guner
AAPS PharmSciTech 22, 1-23, 2021
392021
Kinetic and microhydrodynamic modeling of fenofibrate nanosuspension production in a wet stirred media mill
G Guner, D Yilmaz, E Bilgili
Pharmaceutics 13 (7), 1055, 2021
162021
Use of bead mixtures as a novel process optimization approach to nanomilling of drug suspensions
G Guner, M Kannan, M Berrios, E Bilgili
Pharmaceutical Research 38 (7), 1279-1296, 2021
152021
Analysis of heat generation during the production of drug nanosuspensions in a wet stirred media mill
G Guner, N Seetharaman, S Elashri, M Mehaj, E Bilgili
International Journal of Pharmaceutics 624, 122020, 2022
112022
Effects of bead packing limit concentration on microhydrodynamics-based prediction of breakage kinetics in wet stirred media milling
G Guner, D Yilmaz, D Eskin, E Bilgili
Powder Technology 403, 117433, 2022
92022
Impact of solvents during wet stirred media milling of cross-linked biopolymer suspensions
M Azad, G Guner, A Afolabi, R Davé, E Bilgili
Advanced Powder Technology 32 (12), 4562-4575, 2021
82021
An enthalpy-balance model for timewise evolution of temperature during wet stirred media milling of drug suspensions
G Guner, S Elashri, M Mehaj, N Seetharaman, HF Yao, DJ Clancy, ...
Pharmaceutical Research 39 (9), 2065-2082, 2022
62022
Nanoseeded desupersaturation and dissolution tests for elucidating supersaturation maintenance in amorphous solid dispersions
G Guner, A Amjad, M Berrios, M Kannan, E Bilgili
pharmaceutics 15 (2), 450, 2023
52023
Predicting the Temperature Evolution during Nanomilling of Drug Suspensions via a Semi-Theoretical Lumped-Parameter Model
G Guner, D Yilmaz, HF Yao, DJ Clancy, E Bilgili
Pharmaceutics 14 (12), 2840, 2022
32022
A combined isolation and formulation approach to convert nanomilled suspensions into high drug-loaded composite particles that readily reconstitute
A Coelho, L Schenck, G Guner, A Punia, E Bilgili
Powders 1 (2), 88-110, 2022
32022
Microhydrodynamic, Kinetic and Thermal Modeling of Wet Media Milling for Process Optimization and Intensification
G Guner
New Jersey Institute of Technology, 2022
32022
Do Mixtures of Beads with Different Sizes Improve Wet Stirred Media Milling of Drug Suspensions?
G Guner, M Mehaj, N Seetharaman, S Elashri, HF Yao, DJ Clancy, ...
Pharmaceutics 15 (9), 2213, 2023
12023
Development of a Semi-Mechanistic Modeling Framework for Wet Bead Milling of Pharmaceutical Nanosuspensions
DJ Clancy, G Guner, S Chattoraj, H Yao, MC Faith, Z Salahshoor, ...
Pharmaceutics 16 (3), 394, 2024
2024
A Novel PBM for Nanomilling of Drugs in a Recirculating Wet Stirred Media Mill: Impacts of Batch Size, Flow Rate, and Back-Mixing
H Heidari, N Muanpaopong, G Guner, HF Yao, DJ Clancy, E Bilgili
Pharmaceutics 16 (3), 353, 2024
2024
Thermal Analysis of the Wet Stirred Media Milling Process Used for the Production of Drug Nanoparticle Suspensions
G Guner, N Seetharaman, S Elashri, M Mehaj, E Bilgili
2022 AIChE Annual Meeting, 2022
2022
Cross-Linked Biopolymer Nanosuspension Preparation: Impact of Solvents
M Azad, G Guner, A Afolabi, R Dave, E Bilgili
2021 AIChE Annual Meeting, 2021
2021
A Combined Kinetic–Microhydrodynamic Analysis of the Fenofibrate Nanosuspension Production in a Wet Stirred Media Mill
G Guner, D Yilmaz, E Bilgili
2021 AIChE Annual Meeting, 2021
2021
Kinetic and Microhydrodynamic Modeling of Fenofibrate Nanosuspension Production in a Wet Stirred Media Mill. Pharmaceutics 2021, 13, 1055
G Guner, D Yilmaz, E Bilgili
s Note: MDPI stays neutral with regard to jurisdictional claims in published …, 2021
2021
A Novel Intensification Strategy for Wet Media Milling of Drug Suspensions: Bead Mixtures
G Guner, M Kannan, M Berrios, N Parker, E Bilgili
Presented at the 1st International Electronic Conference on Pharmaceutics 1, 15, 2020
2020
Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.
Articles 1–19